evaluation the effect of Alnavar drug on patients with low ovarian reserve in ivf cycle
Phase 3
Recruiting
- Conditions
- diminished ovarian reserve in IVF cycle.Female infertility of other originN97.8
- Registration Number
- IRCT20221016056198N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Patients with hystory of previous cycle ;
that who fulfilled at least two of the following criteria were admitted: Antral follicle count (AFC) <?5;Antimullerian hormone (AMH)?<?1,1?ng/ml;Less than three oocytes obtained in the previous cycle;
Exclusion Criteria
uterine abnormalities,
recent or current history of any current untreated endocrine abnormality,
unilateral or bilateral hydrosalpinx
contraindications for the use of gonadotropins
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of continuous pregnancy is defined despite the intrauterine gestational sac with a fetal pole that shows cardiac activity during the 9th to 10th week of pregnancy. Timepoint: 9-10week after embryo transfer. Method of measurement: trans vaginal sonography.;Clinical pregnancy rate, which is defined as the presence of an intrauterine gestational sac in the 7th week of pregnancy. Timepoint: 7week after embryo transfer. Method of measurement: trans vaginal sonography.
- Secondary Outcome Measures
Name Time Method Implantation rate per number of transferred embryos. Timepoint: 3-5 weeks after embryo transfer. Method of measurement: trans vaginal sonography.